Anna Sussman | VP, IR and Corporate Communications |
Patrick Mahaffy | President and CEO |
Dr. Tom Harding | Chief Scientific Officer |
Dr. Lindsey Rolfe | Chief Medical Officer |
Dan Muehl | CFO |
Gavin Scott | JP Morgan |
Paul Choi | Goldman Sachs |
Good morning. My name is Julienne, and I will be your conference operator today. At this time, I would like to welcome everyone to Clovis Oncology Q3 2021 Operating Results Webcast and Conference call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.